No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The cash inflow associated with the aggregate amount received by the entity through sale or maturity of long-term marketable securities (trading, held-to-maturity, or available-for-sale) during the period.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Aggregate value of stock issued during the period related to the Employee benefit trust.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Aggregate value of preferred stock issued during the period related to conversions and redemptions.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Description of significant transactions and events, including business combinations other than the Wyeth acquisition, that occurred during the period.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The cash inflow associated with the aggregate amount received by the entity through sale or maturity of short term marketable securities (trading, held-to-maturity, or available-for-sale) with original maturities of more than 90 days during the period.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
This element represents (i) carrying amount as of the balance sheet date of payments made in advance for income and other taxes, which will be charged against earnings within one year or the normal operating cycle, if longer as well as the current portion of the aggregate tax effects as of the balance sheet date of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after deducting the allocated valuation allowance, if any, to reduce such amount to net realizable value; and (ii) aggregate carrying amount, as of the balance sheet date, of current assets not separately presented elsewhere in the balance sheet.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The cash outflow from a repayment of a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year) plus the cash outflow from a repayment of a borrowing having initial term of repayment within three months net of the cash inflow of a borrowing having initial term of repayment within three months.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
This element represents (i) the total amount of other operating income, not previously categorized, from items that are associated with the entity's normal revenue producing operation; and (ii) recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales, as well as excludes research and development expenses and selling, informational and administrative expenses.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
The cash inflow from a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year) plus the cash inflow from a borrowing having initial term of repayment within three months net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
This element represents (i)the noncurrent portion as of the balance sheet date of the aggregate carrying amount of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after the valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference; and (ii) the aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed i
n the balance sheet due to materiality considerations. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Description of cost-reduction initiatives associated with a comprehensive plan to integrate acquired operations, generate cost savings and capture synergies across the company; as well as costs incurred in connection with the Wyeth acquisition. These costs include (i) restructuring activities, including exit and disposal activities, the major types of costs associated with the plan activities and the accrual balance at the end of the period; (ii) integration costs, which represent external, incremental costs directly related to integrating acquired businesses; (iii) implementation costs, which represent external, incremental costs directly related to implementing cost-reduction initiatives prior to the Wyeth acquisition and primarily include expenditures related to system and process standardization and the expansion of shared services. Costs related to Pfizer's cost-reduction initiatives incurred after the Wyeth acquisition, other than additional depreciation-asset restructuring, are inclu
ded in Restructuring charges and certain acquisition-related costs on the income statement; (iv) additional depreciation-asset restructuring, which represents the impact of changes in the estimated useful lives of assets involved in restructuring actions; and (v) transaction costs, representing external costs directly related to effecting the acquisition of Wyeth.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Number of preferred stock shares issued during the period related to conversions and redemptions.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
This element represents the complete disclosure related to financial instruments, which may include i) selected financial assets and liabilities; ii) investments in debt and equity securities; iii) short-term borrowings; iv) long-term debt; v)derivative financial instruments and hedging activities; and vi) credit risk.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
Number of shares issued during the period related to the Employee benefit trust.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
This element represents (i) restructuring charges, which are amounts charged against earnings in the period for incurred and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a program that is planned and controlled by management, and materially changes either the scope of a business undertaken by an entity, or the manner in which that business is conducted; and (ii) acquisition-related costs, which are costs incurred to effect a business combination which costs have been expensed during the period. Such costs can include transaction costs such as banking, legal, accounting and other costs directly related to effect a business combination as well as external, incremental costs of integration planning that are directly related to a business combination, including costs associated with preparing for systems and other integration activities.
No authoritative reference available.
This item represents the gains on disposals of product lines, property, plant and equipment, investments, intangibles and other assets, none treated as discontinued operations.
No authoritative reference available.
This element represents (i) the current portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax. A current taxable temporary difference is a difference between the tax basis and the carrying amount of a current asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the e
xpected reversal date of the temporary difference; and (ii) the aggregate carrying amount, as of the balance sheet date, of current obligations not separately disclosed in the balance sheet due to materiality considerations. Current liabilities are expected to be paid within one year (or the normal operating cycle, if longer).
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
This element represents share movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.
No authoritative reference available.